SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
Clinical trial NCT07051603 · RECRUITING
Trial details
- NCT number
- NCT07051603
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2026-01-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.